Long X - Search Results

1

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas.

Liu J, Yang X, Ji Q, Yang L, Li J, Long X, Ye M, Huang K, Zhu X. Liu J, et al. Among authors: long x. Front Oncol. 2022 Jul 19;12:875131. doi: 10.3389/fonc.2022.875131. eCollection 2022. Front Oncol. 2022. PMID: 35928883 Free PMC article.

2

A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.

Luo H, Tao C, Long X, Huang K, Zhu X. Luo H, et al. Among authors: long x. Aging (Albany NY). 2021 Jun 10;13(12):16198-16218. doi: 10.18632/aging.203146. Epub 2021 Jun 10. Aging (Albany NY). 2021. PMID: 34114970 Free PMC article.

3

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma.

Luo H, Tao C, Long X, Zhu X, Huang K. Luo H, et al. Among authors: long x. Bioengineered. 2021 Dec;12(1):7765-7779. doi: 10.1080/21655979.2021.1985340. Bioengineered. 2021. PMID: 34617871 Free PMC article.

4

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma.

Lin L, Huang K, Tu Z, Zhu X, Li J, Lei K, Luo M, Wang P, Gong C, Long X, Wu L. Lin L, et al. Among authors: long x. Front Oncol. 2021 Oct 27;11:738651. doi: 10.3389/fonc.2021.738651. eCollection 2021. Front Oncol. 2021. PMID: 34778054 Free PMC article.

5

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.

Liu F, Tu Z, Liu J, Long X, Xiao B, Fang H, Huang K, Zhu X. Liu F, et al. Among authors: long x. Biosci Rep. 2022 Jan 28;42(1):BSR20212378. doi: 10.1042/BSR20212378. Biosci Rep. 2022. PMID: 34988580 Free PMC article.

6

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma.

Jiang Y, Ji Q, Long X, Wang P, Tu Z, Zhang X, Zhu X, Huang K, Li J. Jiang Y, et al. Among authors: long x. Front Immunol. 2022 Feb 21;13:810832. doi: 10.3389/fimmu.2022.810832. eCollection 2022. Front Immunol. 2022. PMID: 35265072 Free PMC article.

7

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.

Tu Z, Ouyang Q, Long X, Wu L, Li J, Zhu X, Huang K. Tu Z, et al. Among authors: long x. Front Immunol. 2022 Mar 25;13:837512. doi: 10.3389/fimmu.2022.837512. eCollection 2022. Front Immunol. 2022. PMID: 35401558 Free PMC article.

8

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.

Tu Z, Peng J, Long X, Li J, Wu L, Huang K, Zhu X. Tu Z, et al. Among authors: long x. Front Immunol. 2022 May 3;13:844736. doi: 10.3389/fimmu.2022.844736. eCollection 2022. Front Immunol. 2022. PMID: 35592314 Free PMC article.

9

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity.

Tu Z, Li J, Long X, Wu L, Zhu X, Huang K. Tu Z, et al. Among authors: long x. Oxid Med Cell Longev. 2022 May 10;2022:9408886. doi: 10.1155/2022/9408886. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35592529 Free PMC article.

10

Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer.

Lei K, Luo M, Tu Z, Lv S, Liu J, Gong C, Ye M, Wu M, Sheng Y, Long X, Li J, Zhu X, Huang K. Lei K, et al. Among authors: long x. Cancer Cell Int. 2022 Sep 5;22(1):275. doi: 10.1186/s12935-022-02689-6. Cancer Cell Int. 2022. PMID: 36064705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,343 results

Search Page

Filters